Product Information
SUMATRIPTAN SUCC 25 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2842 per EA under NDC 00378563059. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
25 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378563059
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA077744On Market Since
8/10/2009
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN SUCC 25 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 68.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2842 per EA |
|---|---|
| All-time high | $1.1120 (Feb 12, 2014) |
| All-time low | $0.2584 (Mar 18, 2026) |
| 52-week high | $0.3416 |
| 52-week low | $0.2584 |
| Median price | $0.7138 |
| Average price | $0.6576 |
| Largest weekly change | +48.8% (May 22, 2019) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN SUCC 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN SUCC 25 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.2842 per EA (NDC 00378563059), effective Jun 24, 2026.
How has the price of SUMATRIPTAN SUCC 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN SUCC 25 MG TABLET has declined 68.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN SUCC 25 MG TABLET?
Since Nov 28, 2013, the NADAC for SUMATRIPTAN SUCC 25 MG TABLET has ranged from a low of $0.2584 (Mar 18, 2026) to a high of $1.1120 (Feb 12, 2014), with a median of $0.7138 per EA.
Are there cheaper alternatives to SUMATRIPTAN SUCC 25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SUMATRIPTAN SUCC 25 MG TABLET, but none are currently priced below it.
Who manufactures SUMATRIPTAN SUCC 25 MG TABLET?
SUMATRIPTAN SUCC 25 MG TABLET (NDC 00378563059) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification